These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1233206)

  • 1. The effect of buffered aspirin on plasma indomethacin.
    Garnham JC; Raymond K; Shotton E; Turner P
    Eur J Clin Pharmacol; 1975 Feb; 8(2):107-13. PubMed ID: 1233206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aspirin on serum indomethacin.
    Champion GD; Paulus HE; Mongan E; Okun R; Pearson CM
    Clin Pharmacol Ther; 1972; 13(2):239-44. PubMed ID: 4552821
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo-in vitro correlations with various aspirin formulations.
    Alcorn GJ; Lücker PW; Procaccini RL; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):761-7. PubMed ID: 3448453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.
    Kwan KC; Breault GO; Davis RL; Lei BW; Czerwinski AW; Besselaar GH; Duggan DE
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):451-76. PubMed ID: 731412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin--aspirin interaction: a clinical appraisal.
    Brooks PM; Walker JJ; Bell MA; Buchanan WW; Rhymer AR
    Br Med J; 1975 Jul; 3(5975):69-71. PubMed ID: 1095133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concurrent administration of aspirin and indomethacin on serum concentrations.
    Lindquist B; Jensen KM; Johansson H; Hansen T
    Clin Pharmacol Ther; 1974 Mar; 15(3):247-52. PubMed ID: 4593119
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
    Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
    Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.
    Kaldestad E; Hansen T; Brath HK
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):199-207. PubMed ID: 1233265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability studies on fast release formulations of indomethacin.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2002; 141(3):176-80. PubMed ID: 12197414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):469-74. PubMed ID: 4055157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.
    Rubin A; Rodda BE; Warrick P; Gruber CM; Ridolfo AS
    Arthritis Rheum; 1973; 16(5):635-45. PubMed ID: 4582611
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
    Viganò G; Garagiola U; Gaspari F
    Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of salicylate and indomethacin in coeliac disease.
    Parsons RL; Kaye CM; Raymond K
    Eur J Clin Pharmacol; 1977 Jul; 11(6):473-7. PubMed ID: 891594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability.
    Rowe JS; Carless JE
    J Pharm Pharmacol; 1981 Sep; 33(9):561-4. PubMed ID: 6117632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, and effect on gastric mucosa, of buffered and non-buffered tablets of acetylsalicylic acid.
    Linnoila M; Lehtola J
    Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):61-4. PubMed ID: 885664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg.
    Olugemo K; Solorio D; Sheridan C; Young CL
    Postgrad Med; 2015 Mar; 127(2):223-31. PubMed ID: 25639879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.